Telomerase is a ribonucleoprotein that synthesizes telomeric DNA on chromosomal ends. While telomerase is undetectable in most normal somatic tissues, telomerase activation has been detected by a polymerase chain reaction (PCR)-based assay (TRAP) in many immortal cell lines and various cancers, incl
Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer
✍ Scribed by Eugen Plas; Veronica A. Carroll; Ruth Jilch; Rainer Simak; Judith Mihaly; Sebastian Melchior; Joachim W. Thüroff; Bernd R. Binder; Heinz Pflüger
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 144 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Fibroblast growth factor receptor 4 (FGFR4) is a member of a family of transmembrane receptors with ligand‐induced tyrosine kinase activity. The Glycine (Gly) to Arginine (Arg) polymorphism at codon 388 (Gly388Arg), which encodes an amino acid in the transmembrane part of the FGFR4 gene
## Background: Several recent studies have suggested an important role of the apoptosis suppressing bcl-2 gene product in prostate cancer progression to an androgen-insensitive disease. ## Methods: Using double-labeling techniques, we have investigated the nuclear androgen receptor (ar) status an
## Background: Benign prostatic hyperplasia (bph) involves qualitative and quantitative alterations in extracellular matrix (ecm) components affecting stromal-epithelial interactions. glycosaminoglycans (gags) are polysaccharide components of the ecm whose role in the development of bph is under in
The tumour growth kinetics (cell proliferation and apoptosis) of ten hormone-refractory locally recurrent prostate cancers were compared with their matched untreated primary tumour specimens. All recurrent tumours had a higher cell proliferation activity, as defined by Ki-67 immunohistochemistry, th